"Movement Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Descriptor ID |
D009069
|
| MeSH Number(s) |
C10.228.662
|
| Concept/Terms |
Movement Disorders- Movement Disorders
- Movement Disorder
- Movement Disorder Syndromes
- Movement Disorder Syndrome
- Dyskinesia Syndromes
- Dyskinesia Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Movement Disorders".
Below are MeSH descriptors whose meaning is more specific than "Movement Disorders".
This graph shows the total number of publications written about "Movement Disorders" by people in this website by year, and whether "Movement Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 4 | 0 | 4 |
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 3 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 4 | 1 | 5 |
| 2004 | 4 | 3 | 7 |
| 2005 | 1 | 1 | 2 |
| 2006 | 4 | 1 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 8 | 0 | 8 |
| 2010 | 8 | 1 | 9 |
| 2011 | 7 | 2 | 9 |
| 2012 | 7 | 0 | 7 |
| 2013 | 15 | 1 | 16 |
| 2014 | 11 | 2 | 13 |
| 2015 | 7 | 0 | 7 |
| 2016 | 6 | 0 | 6 |
| 2017 | 8 | 0 | 8 |
| 2018 | 3 | 1 | 4 |
| 2019 | 5 | 0 | 5 |
| 2020 | 2 | 1 | 3 |
| 2021 | 10 | 0 | 10 |
| 2022 | 3 | 0 | 3 |
| 2023 | 8 | 0 | 8 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Movement Disorders" by people in Profiles.
-
Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders. Brain. 2024 Apr 04; 147(4):1436-1456.
-
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS Drugs. 2024 Apr; 38(4):239-254.
-
Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Sci. 2024 Mar 15; 458:122925.
-
Allelic strengths of encephalopathy-associated UBA5 variants correlate between in vivo and in vitro assays. Elife. 2023 Dec 11; 12.
-
Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders. Brain. 2023 12 01; 146(12):5031-5043.
-
De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities, and variable movement abnormalities. Am J Med Genet A. 2024 Jan; 194(1):17-30.
-
Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals. Eur J Hum Genet. 2023 08; 31(8):905-917.
-
Iron Deficiency in Attention-Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Internalizing and Externalizing Disorders, and Movement Disorders. Child Adolesc Psychiatr Clin N Am. 2023 04; 32(2):451-467.
-
Peripherally-induced Movement Disorders: An Update. Tremor Other Hyperkinet Mov (N Y). 2023; 13:8.
-
COVID19-associated new-onset movement disorders: a follow-up study. J Neurol. 2023 May; 270(5):2409-2415.